Susunod

Auto-play

CAR T-Cell Therapy for Relapsed/Refractory CLL

2 Mga view • 07/14/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

The panelists provide insight on the use of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia and the TRANSCEND CLL-004 trial of liso-cel (JCAR017) in relapsed/refractory disease.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play